Tscan Therapeutics Inc (TCRX) valuation · rev $10.3M
Tscan Therapeutics Inc (TCRX) rev $10.3M.
| Metric | Value |
|---|---|
| Market cap | $62.1M |
| Revenue | $10.3M |
| P/S | 6.0 |
| P/B | 0.6 |
TCRX valuation FAQ
What is TCRX's market cap?
Tscan Therapeutics Inc (TCRX) market cap is $62.1M on the latest cached fundamentals snapshot.
What is TCRX's latest revenue?
Latest cached Tscan Therapeutics Inc (TCRX) revenue was $10.3M. Statements: https://lician.com/financials/tcrx
What is TCRX's price-to-sales ratio?
Tscan Therapeutics Inc (TCRX) price-to-sales (P/S) is 6.0, cached market cap $62.1M divided by revenue $10.3M.
What is TCRX's price-to-book ratio?
Tscan Therapeutics Inc (TCRX) price-to-book (P/B) is 0.6 on the latest cached fundamentals snapshot.
How many TCRX valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Tscan Therapeutics Inc (TCRX): Market cap, Revenue, P/S, and P/B.
Where is TCRX valuation listed?
Cached valuation multiples for Tscan Therapeutics Inc (TCRX) are listed at https://lician.com/valuation/tcrx.
Not investment advice. Cached rows, not a live tape.